Deep technology, backed by science, is the key to product differentiation. Philip Morris International (PMI) relies on state of the art mechanical, chemical and electronic features in its core product (please see details on PMI’s official website: www.pmi.com).
We at PM Equity Partner would be keen to invest in companies that develop technologies either at the component or finished level with proprietary IP that are essential to further advancing PMI industry-leading products, such as inhalation and aerosol technology, chemical formulation technology, micro-scaled heating, bio-authentication, machine learning in consumer behavior, and other future technologies that could be relevant to PMI’s next generation products, in both nicotine and beyond.